TrialJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2014

CALGB 30704 (Alliance): A randomized phase II study to assess the efficacy of pemetrexed or sunitinib or pemetrexed plus sunitinib in the second-line treatment of advanced non-small-cell lung cancer.

Rebecca S Heist et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.